For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
3
views
0
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      2,294
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      Targeting Resistance in Egfr-Mutant Non-Small Cell Lung Cancer (Nsclc): Preclinical Evidence Supporting the Combination of Egfr Tyrosine Kinase Inhibitors (Tkis) Azd9291 and Gefitinib with Molecularly Targeted Agents and Immunotherapeutics

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Title: Annals of Oncology
          Abbreviated Title: Annals of Oncology
          Publisher: Oxford University Press (OUP)
          ISSN (Print): 09237534
          Publication date Created: September 2014
          Publication date (Print): September 2014
          Volume: 25
          Page: iv155
          Article
          DOI: 10.1093/annonc/mdu331.26
          SO-VID: 44e32218-5d14-4bd6-bdc9-4d65a4f571dc
          Copyright © © 2014
          License:

          https://www.elsevier.com/tdm/userlicense/1.0/

          http://www.elsevier.com/open-access/userlicense/1.0/

          History

          Data availability:

          Comments

          Comment on this article